| Mrs Gracy George Isaac, OT | |
|
6905 W Wilshire Blvd Ste B, Oklahoma City, OK 73132-5494 | |
| (405) 445-1295 | |
| Not Available |
| Full Name | Mrs Gracy George Isaac |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 6905 W Wilshire Blvd Ste B, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437364437 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 611 (Oklahoma) | Secondary |
| 225X00000X | Occupational Therapist | OT611 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Gracy George Isaac, OT 8613 Nw 69th Cir, Oklahoma City, OK 73132-3763 Ph: () - | Mrs Gracy George Isaac, OT 6905 W Wilshire Blvd Ste B, Oklahoma City, OK 73132-5494 Ph: (405) 445-1295 |
News Archive
Incidence rates of the most common type of liver cancer have significantly increased in Queensland since the mid-90s, new data shows.
Advanced Cell Technology or "ACT" announced today that its research involving therapeutic cell types obtained from induced pluripotent stem (iPS) cells has been featured in several leading news media outlets: Scientific American, USA Today and Newsweek.
Olympus, a precision technology leader, creating innovative opto-digital solutions in healthcare, life science and consumer electronics products, today announced the introduction of its improved user-friendly Endo Capsule Software version 1.02A, a customized and comprehensive system for examining high resolution small bowel images.
A pioneering world first robotics system operation is to be conducted at Glenfield Hospital Leicester thanks to expertise at the University of Leicester and University Hospitals of Leicester.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced the initiation of a Phase 2 clinical trial of XOMA 052, its antibody to interleukin-1 beta (IL-1 beta), in Type 1 diabetes patients. Funding for the trial is being provided by the Juvenile Diabetes Research Foundation International, the largest patient advocacy organization of Type 1 diabetes research worldwide.
› Verified 7 days ago
Jovan Pride, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 5701 Se 74th St Ste G, Oklahoma City, OK 73135 Phone: 405-610-1909 Fax: 405-610-1910 | |
Tung Le, MOTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3327 Nw 50th St, Oklahoma City, OK 73112 Phone: 405-946-7300 | |
Dr. Rachele Quinones, OTD, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6525 N Meridian Ave, Ste, Oklahoma City, OK 73116 Phone: 405-721-1115 | |
Keli A Boone, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1404 Nw 122nd St, Oklahoma City, OK 73114 Phone: 405-749-8131 | |
Caroline Jean Grubbs, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6400 N Santa Fe Ave, Suite B, Oklahoma City, OK 73116 Phone: 405-840-2903 Fax: 405-840-3256 | |
Ms. Denise Lashaun Shaw, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2828 Nw 57th St Ste 302, Oklahoma City, OK 73112 Phone: 405-840-1253 | |
Kallie Kim, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4220 Se 34th St, Oklahoma City, OK 73165 Phone: 785-213-1894 |